Paul Ruff to Recurrence
This is a "connection" page, showing publications Paul Ruff has written about Recurrence.
Connection Strength
0,080
-
A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen. Cancer Chemother Pharmacol. 2009 Sep; 64(4):763-8.
Score: 0,080